📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Adjuvant Rituximab-Exploratory Trial in Young People With Graves Disease. (2022)

First Author: Cheetham TD

Attributed to: Plasma-cell depletion therapy for severe Graves' disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1210/clinem/dgab763

PubMed Identifier: 34687316

Publication URI: http://europepmc.org/abstract/MED/34687316

Type: Journal Article/Review

Volume: 107

Parent Publication: The Journal of clinical endocrinology and metabolism

Issue: 3

ISSN: 0021-972X